Skip to content
2000
Volume 16, Issue 28
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Lys49-phospholipase A2 homologues constitute a large family of toxins present in the venoms of viperid snake species, which despite lacking catalytic activity, cause significant skeletal muscle necrosis. The main structural determinants of this toxic effect have been experimentally mapped to a region near their C-terminus (115-129), which combines cationic and hydrophobic/aromatic amino acid residues. Short (13-mer) synthetic peptides representing this C-terminal region can mimick several of the effects of Lys49 PLA2 homologues. In addition to their ability to damage muscle cells, these peptides display antibacterial, antiendotoxic, antifungal, antiparasite, and antitumor activities, as well as VEGF-receptor 2 (KDR)-binding and heparin-binding properties. Modifications of their sequences have shown possibilities to enhance their effects upon prokaryotic cells, while decreasing toxicity for eukaryotic cells. This review presents an updated summary on the biomimetic actions exerted by such peptides, and highlights their potential value as molecular tools or as drug leads in diverse biomedical areas.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/138161210793292456
2010-09-01
2025-05-05
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/138161210793292456
Loading

  • Article Type:
    Research Article
Keyword(s): antimicrobial; antitumor; biomimetic; heparin; phospholipase A2; snake venom; Synthetic peptides; VEGF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test